Financial results - PHARMICS SRL

Financial Summary - Pharmics Srl
Unique identification code: 23200539
Registration number: J12/441/2008
Nace: 4646
Sales - Ron
12.658.027
Net Profit - Ron
2.934.421
Employee
15
The most important financial indicators for the company Pharmics Srl - Unique Identification Number 23200539: sales in 2023 was 12.658.027 euro, registering a net profit of 2.934.421 euro and having an average number of 15 employees. Firma isi desfasoara activitatea in domeniul Comert cu ridicata al produselor farmaceutice having the NACE code 4646.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Pharmics Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 2.626.098 3.293.109 4.095.294 3.711.684 3.293.427 7.353.878 6.203.915 7.142.597 11.299.580 12.658.027
Total Income - EUR 2.778.485 3.479.986 4.182.601 3.861.257 3.314.203 7.452.948 6.257.077 7.242.858 11.898.973 13.549.429
Total Expenses - EUR 1.837.023 2.353.283 2.865.342 2.760.984 2.373.555 4.867.577 4.312.042 5.331.760 9.249.752 10.051.698
Gross Profit/Loss - EUR 941.462 1.126.703 1.317.260 1.100.273 940.648 2.585.371 1.945.035 1.911.098 2.649.221 3.497.731
Net Profit/Loss - EUR 793.487 954.310 1.115.340 924.668 781.313 2.165.708 1.640.560 1.610.952 2.238.798 2.934.421
Employees 12 10 13 12 14 15 15 14 15 15
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 12.4%, from 11.299.580 euro in the year 2022, to 12.658.027 euro in 2023. The Net Profit increased by 702.412 euro, from 2.238.798 euro in 2022, to 2.934.421 in the last year.

Check the financial reports for the company - Pharmics Srl

Rating financiar

Financial Rating -
Pharmics Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Pharmics Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmics Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmics Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmics Srl - CUI 23200539

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 1.498.248 1.740.094 1.951.983 1.877.551 1.733.794 1.620.178 1.570.680 2.118.485 2.945.852 4.267.212
Current Assets 2.296.306 2.702.282 2.747.448 2.508.881 2.609.122 4.180.086 4.493.228 5.029.551 8.279.406 9.305.942
Inventories 296.410 344.318 396.603 497.102 721.096 1.262.395 1.184.193 1.177.803 1.335.772 1.139.830
Receivables 873.152 763.879 601.226 660.863 792.092 1.159.601 2.075.771 2.840.722 4.455.268 4.972.474
Cash 1.126.744 1.594.085 1.749.618 1.350.916 1.095.934 1.758.091 1.233.263 1.011.026 2.488.366 3.193.638
Shareholders Funds 2.759.769 3.158.919 3.005.596 3.139.720 3.359.718 4.537.335 4.523.951 5.105.324 3.986.001 6.908.335
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 1.037.190 1.291.897 1.700.612 1.248.542 987.887 1.267.842 1.548.505 2.053.292 7.247.518 6.671.511
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 9.305.942 euro in 2023 which includes Inventories of 1.139.830 euro, Receivables of 4.972.474 euro and cash availability of 3.193.638 euro.
The company's Equity was valued at 6.908.335 euro, while total Liabilities amounted to 6.671.511 euro. Equity increased by 2.934.421 euro, from 3.986.001 euro in 2022, to 6.908.335 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Pharmics Srl

Comments - Pharmics Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.